Agilon Health (AGL) Net Income towards Common Stockholders: 2020-2025
Historic Net Income towards Common Stockholders for Agilon Health (AGL) over the last 6 years, with Q1 2025 value amounting to $14.0 million.
- Agilon Health's Net Income towards Common Stockholders rose 25084.58% to $14.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $14.6 million, marking a year-over-year increase of 11983.5%. This contributed to the annual value of -$9.8 million for FY2024, which is 8545.67% up from last year.
- As of Q1 2025, Agilon Health's Net Income towards Common Stockholders stood at $14.0 million, which was up 25084.58% from $640000.0 recorded in Q4 2024.
- Over the past 5 years, Agilon Health's Net Income towards Common Stockholders peaked at $14.0 million during Q1 2025, and registered a low of -$63.3 million during Q4 2023.
- In the last 5 years, Agilon Health's Net Income towards Common Stockholders had a median value of -$976000.0 in 2023 and averaged -$6.3 million.
- Within the past 5 years, the most significant YoY rise in Agilon Health's Net Income towards Common Stockholders was 130046.62% (2023), while the steepest drop was 390169.49% (2023).
- Quarter analysis of 5 years shows Agilon Health's Net Income towards Common Stockholders stood at -$20.9 million in 2021, then grew by 27.96% to -$15.1 million in 2022, then plummeted by 320.06% to -$63.3 million in 2023, then soared by 101.01% to $640000.0 in 2024, then soared by 2087.5% to $14.0 million in 2025.
- Its Net Income towards Common Stockholders was $14.0 million in Q1 2025, compared to $640000.0 in Q4 2024 and -$1.2 million in Q3 2024.